. Author manuscript; available in PMC: 2015 Apr 15.

Published in final edited form as: J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):551–556. doi: 10.1097/QAI.0000000000000085

Table 1. Demographic and clinical characteristics.

Characteristic, N (%)	Total	TB^* (N=5)	No TB (N=196)	p-value
Age (years)^†	34 (28-40)	33 (32-47)	34 (28-40)	0.45
Female	140 (70%)	2 (40%)	138 (70%)	0.15
CD4 count (cells/μL)^†	138 (84-207)	175 (154-183)	137 (81-207)	0.34
Prior TB	12 (6%)	1 (20%)	11 (6%)	0.19
Cough	105 (52%)	3 (60%)	102 (52%)	0.73
Fever	64 (32%)	4 (80%)	60 (31%)	0.02
Night sweats	64 (33%)	2 (40%)	62 (32%)	0.69
Weight loss	68 (34%)	3 (60%)	65 (33%)	0.21
WHO symptom screen positive	159 (79%)	5 (100%)	154 (79%)	0.25
Elevated POC-CRP	29 (14%)	4 (80%)	25 (13%)	<0.001
POC-CRP (mg/L)^†	2.5 (2.5-4.2)	32.0 (15.0-45.5)	2.5 (2.5-3.9)	0.003

Abbreviations: TB (tuberculosis); WHO (World Health Organization); POC-CRP (point-of-care C-reactive protein).

Legend:

TB defined as definite (smear- and/or culture-confirmed TB) or probable cases (TB treatment without microbiologic confirmation but documented improvement with treatment).

^†

Continuous variables presented as medians (interquartile range).